People In The News | GenomeWeb

NEW YORK (GenomeWeb News) – BioFire Diagnostics has appointed Robert Lollini as CFO.

Lollini most recently served as CEO, and formerly as CFO of Myrexis, a Utah-based biotechnology company. He remains a member of its board of directors. From 1993 to 2007, Lollini held multiple executive positions at drug-delivery company Iomed, which was acquired in May 2007. Earlier in his career, he held various executive management positions at RP Scherer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.